Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Jan;39(1):159–163. doi: 10.1128/iai.39.1.159-163.1983

Interferon potentiation occurs at a pretranscriptive stage.

L A Schwarz, W R Fleischmann Jr
PMCID: PMC347919  PMID: 6185431

Abstract

Combination of interferon-gamma (IFN-gamma) with a mixture of IFN-alpha and IFN-beta (IFN-alpha/beta) produce a potentiated antiviral state. The onset of induction of the potentiated antiviral state was observed to be more rapid than the onset of induction of either IFN-gamma or IFN-alpha/beta separately. The onset of viral resistance to combined IFN-gamma and IFN-alpha/beta (25 U/ml each) began after 2 h, compared with 4 h for IFN-alpha/beta (25 U/ml) alone and 8 h for IFN-gamma (25 U/ml) alone. By adding actinomycin D at various times after interferon treatment, this more rapid onset of induction of the potentiated antiviral state was shown to be the result of a more rapid onset of cellular transcription. To determine whether increased concentrations of IFN-alpha/beta acted through a similar mechanism, we performed kinetic experiments with several concentrations of IFN-alpha/beta and with combined preparations of IFN-gamma and IFN-alpha/beta. The findings showed that treatment of cells with the combined interferons and with a high concentration of IFN-alpha/beta resulted in more rapid onset of cellular transcription and more rapid development of the antiviral state. Thus, the cellular response to potentiation appeared to involve perception by the cell of the combined interferons as a higher-than-expected effective concentration of interferon, resulting in more rapid onset of cellular transcription of mRNA for antiviral proteins.

Full text

PDF
159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ankel H., Krishnamurti C., Besançon F., Stefanos S., Falcoff E. Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells. Proc Natl Acad Sci U S A. 1980 May;77(5):2528–2532. doi: 10.1073/pnas.77.5.2528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baron S., Dianzani F. General considerations of the interferon system. Tex Rep Biol Med. 1977;35:1–10. [PubMed] [Google Scholar]
  3. Branca A. A., Baglioni C. Evidence that types I and II interferons have different receptors. Nature. 1981 Dec 24;294(5843):768–770. doi: 10.1038/294768a0. [DOI] [PubMed] [Google Scholar]
  4. Brysk M. M., Tschen E. H., Hudson R. D., Smith E. B., Fleischmann W. R., Jr, Black H. S. The activity of interferon on ultraviolet light-induced squamous cell carcinomas in mice. J Am Acad Dermatol. 1981 Jul;5(1):61–63. doi: 10.1016/s0190-9622(81)70078-1. [DOI] [PubMed] [Google Scholar]
  5. Dianzani F., Baron S. Unexpectedly rapid action of human interferon in physiological conditions. Nature. 1975 Oct 23;257(5528):682–684. doi: 10.1038/257682a0. [DOI] [PubMed] [Google Scholar]
  6. Dianzani F., Buckler C. E., Baron S. Effect of cycloheximide on the antiviral action of interferon. Proc Soc Exp Biol Med. 1969 Feb;130(2):519–523. doi: 10.3181/00379727-130-33595. [DOI] [PubMed] [Google Scholar]
  7. Dianzani F., Salter L., Fleischmann W. R., Jr, Zucca M. Immune interferon activates cells more slowly than does virus-induced interferon. Proc Soc Exp Biol Med. 1978 Oct;159(1):94–97. doi: 10.3181/00379727-159-40291. [DOI] [PubMed] [Google Scholar]
  8. Fleischmann W. R., Jr, Georgiades J. A., Osborne L. C., Johnson H. M. Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. Infect Immun. 1979 Oct;26(1):248–253. doi: 10.1128/iai.26.1.248-253.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fleischmann W. R., Jr, Kleyn K. M., Baron S. Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J Natl Cancer Inst. 1980 Nov;65(5):963–966. [PubMed] [Google Scholar]
  10. Fleischmann W. R., Jr Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. Cancer Res. 1982 Mar;42(3):869–875. [PubMed] [Google Scholar]
  11. Fleischmann W. R., Simon E. H. Effect of interferon on virus production from isolated single cells. J Gen Virol. 1973 Aug;20(2):127–137. doi: 10.1099/0022-1317-20-2-127. [DOI] [PubMed] [Google Scholar]
  12. Iwakura Y., Yonehara S., Kawade Y. Purification of mouse L cell interferon. Essentially pure preparations with associated cell growth inhibitory activity. J Biol Chem. 1978 Jul 25;253(14):5074–5079. [PubMed] [Google Scholar]
  13. Osborne L. C., Georgiades J. A., Johnson H. M. Large-scale production and partial purification of mouse immune interferon. Infect Immun. 1979 Jan;23(1):80–86. doi: 10.1128/iai.23.1.80-86.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES